Steven Horwitz, MD
Memorial Sloan Kettering Cancer Center
7
7
4
N/A
0
9
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Karenza Alexis, MD
Affimed Inc.
Shared therapeutic areas:
Worked with same sponsors:
Won Seog Kim, Dr
Samsung Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Ranjana Advani, MD
Stanford University Medical Center, Stanford, CA, USA
Shared therapeutic areas:
Worked with same sponsors:
Francine Foss, MD
Yale University School of Medicine, New Haven, CT, USA
Shared therapeutic areas:
Worked with same sponsors:
Dolores Caballero, MD
Instituto Biosanitaria de Salamanca, Salamanca, Spain
Shared therapeutic areas:
Worked with same sponsors:
Pierluigi Porcu, MD
Hematopoietic Stem Cell Transplantation, Sidney Kimmel Cancer Center, USA
Shared therapeutic areas:
Worked with same sponsors:
Christopher Fox, MD
Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK
Shared therapeutic areas:
Worked with same sponsors:
Astrid Pavlovsky, MD
Centro de Hematologia, FUNDALEU, Buenos Aires, Argentina
Shared therapeutic areas:
Worked with same sponsors:
Julie Vose, MD
Section of Hematology/Oncology, Nebraska Medical Center, USA
Shared therapeutic areas:
Worked with same sponsors:
Carlos Chiattone, MD
Departamento de Clinica Médica, FCM da Santa Casa de Sao Paulo, Sao Paulo, Brazil
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
A Registry for People With T-cell Lymphoma
Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides
Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.
Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas
Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas
Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma
All 7 trials loaded